Dominick A. Conde

Liza M. Walsh

Katelyn O'Reilly

William E. Solander

Whitney M. Howard

Erin J. D. Austin

Evan Krygowski

Christine Clark

Astellas Pharma Inc

Haimen Pharma Inc

Medivation LLC

Astellas US LLC

Medivation Prostate Therapeutics LLC

Astellas Pharma US Inc

Regents of University of California

SinoTherapeutics Inc

Last Docket Entry Date

Total Docket Entries

ANDA filing triggers Astellas' challenge over generic Xtandi®, asserting core compound patents and claims to `amorphous enzalutamide` in a `solid dispersion`.

2:24-cv-09403 | Astellas Pharma Inc v. Haimen Pharma Inc | Ex Parte

United States District of New Jersey

Name	Ratings
Astellas Pharma US Inc NPE	L4A
Astellas Pharma Inc NPE	L4A
Medivation Prostate Therapeutics LLC	L5A
Medivation LLC	L5A
Astellas US LLC NPE	L4A
Regents Of University Of California NPE	L3B

Name	Ratings
Venable LLP	L5A
Dominick A. Conde	L5A
William E. Solander	L5A
Whitney M. Howard	L4B
Evan Krygowski	L4B
Erin J. D. Austin	---- --
Walsh Pizzi Oreilly Falanga LLPLocal	L3B
Liza M. Walsh	L4B
Katelyn O'Reilly	L3B
Christine Clark	---- --

Name	Ratings
Haimen Pharma Inc	---- --
SinoTherapeutics Inc	---- --